Associate Editor
Dr. Narjust Florez is a clinician-researcher committed to improving cancer care for vulnerable populations, particularly young patients and women with lung cancer. Her clinical interests and research focus on utilizing novel approaches for timely lung cancer diagnosis, targeted therapies for early-stage lung cancer, the unique disease characteristics in young adults with lung cancer, survivorship challenges in lung cancer, and the role of intersectionality in shaping patients’ experiences.
Dr. Florez is originally from Venezuela and graduated first in her medical school class at Universidad Católica Nordestana in the Dominican Republic. She completed her internal medicine residency at Rutgers New Jersey Medical School (recognized as the Department of Medicine's most academic resident in 2015 and 2016) and completed a hematology and clinical oncology fellowship at Mayo Clinic in Rochester, MN, where she served as chief fellow in oncology from 2018 to 2019.
During her time at the University of Wisconsin, she founded the Midwest's first clinic dedicated to women with lung cancer. The clinic rapidly grew and was honored with the North American Cancer Care Team Award for exceptional clinical care at the 2021 World Conference on Lung Cancer.
Bristol Myers Squibb; Catalyst Pharmaceuticals; Foundation One; Merck; Novocure; Nuvation Bio; Takeda
AstraZeneca; Johnson & Johnson; Pfizer
AstraZeneca; Daiichi Sankyo Foundation; Genentech
JAMA Oncology
International Association for the Study of Lung Cancer (Board Member)